Treatment of preclinical hypertrophic cardiomyopathy with diltiazem.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Diltiazem (Primary)
- Indications Hypertrophic cardiomyopathy
- Focus Biomarker; Therapeutic Use
- 07 Apr 2015 Biomarkers information updated
- 22 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 31 Oct 2006 New trial record.